Literature DB >> 2228904

Growth-promoting effects of gastrin on mouse colon cancer cells in vitro: absence of autocrine effects.

Y S Guo1, M Baijal, G F Jin, J C Thompson, C M Townsend, P Singh.   

Abstract

We have previously demonstrated trophic effects of gastrin on mouse colon cancer (MC-26) cells, in vivo, and demonstrated the presence of gastrin receptors (GR) on these cells. The cellular and intracellular mechanism by which gastrin expresses trophic effects on colon cancer cells is, however, as yet unknown. For us to start investigating the possible mechanisms involved, it was important that we first develop an in vitro model, in which gastrin expresses its trophic effects directly on the MC-26 cells. The growth-promoting effects of gastrin on the MC-26 cells were examined in various in vitro culture models, in terms of [3H]thymidine incorporation and cell number. A significant trophic effect of gastrin could be demonstrated on quiescent cells in culture, in the absence of serum. The optimal cell-culture conditions for observing trophic effects of gastrin were defined and included a 24-h period of rapid growth of MC-26 cells in serum-supplemented normal growth medium, followed by a 24-h period of culture in serum-free medium containing an optimal dose (1.0 mM) of thymidine, to achieve growth-arrest of the cells. Addition of gastrin (0.5 to 25 nM) to the quiescent, growth-arrested cells resulted in significant dose-dependent increases in both the incorporation of [3H]thymidine uptake by the cells, and a significant increase in cell number. The concentration of GR on the growth-arrested quiescent MC-26 cells in culture was significantly increased compared to the GR concentration on the control, asynchronized cells. The increased presence of GR on the growth-arrested, synchronized MC-26 cells may have allowed us to observe a significant trophic effect of gastrin on the MC-26 cells, in vitro itself. To determine if gastrin was functioning as an autocrine growth factor for MC-26 cells, we examined the effect of gastrin antibodies on the growth of MC-26 cells; no significant effect of the antigastrin IgG on the growth of MC-26 cells was observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228904     DOI: 10.1007/bf02624612

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  26 in total

Review 1.  Growth factors and intestinal neoplasms.

Authors:  C M Townsend; R D Beauchamp; P Singh; J C Thompson
Journal:  Am J Surg       Date:  1988-03       Impact factor: 2.565

2.  Dynamic characteristics of gastrin release.

Authors:  B M Jackson; D D Reeder; J C Thompson
Journal:  Am J Surg       Date:  1972-02       Impact factor: 2.565

Review 3.  Role of gastrin and cholecystokinin in tumours of the gastrointestinal tract.

Authors:  C B Lamers; J B Jansen
Journal:  Eur J Cancer Clin Oncol       Date:  1988-02

4.  Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture.

Authors:  T Ikeda; Q F Liu; D Danielpour; J B Officer; M Iio; F E Leland; D A Sirbasku
Journal:  In Vitro       Date:  1982-12

Review 5.  Growth regulation of human breast carcinoma occurs through regulated growth factor secretion.

Authors:  M E Lippman; R B Dickson; E P Gelmann; N Rosen; C Knabbe; S Bates; D Bronzert; K Huff; A Kasid
Journal:  J Cell Biochem       Date:  1987-09       Impact factor: 4.429

6.  Inhibition of pentagastrin-stimulated up-regulation of gastrin receptors and growth of mouse colon tumor in vivo by proglumide, a gastrin receptor antagonist.

Authors:  P Singh; S Le; R D Beauchamp; C M Townsend; J C Thompson
Journal:  Cancer Res       Date:  1987-10-01       Impact factor: 12.701

7.  Trophic effects of gastrin on colorectal neoplasms in the rat.

Authors:  D B McGregor; R D Jones; D A Karlin; M M Romsdahl
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

8.  Growth of colorectal carcinoma cells: regulation in vitro by gastrin, pentagastrin and the gastrin-receptor antagonist proglumide.

Authors:  A Imdahl; S Eggstein; C Crone; E H Farthmann
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

9.  Gastrin stimulates growth of colon cancer.

Authors:  O E Winsett; C M Townsend; E J Glass; J C Thompson
Journal:  Surgery       Date:  1986-03       Impact factor: 3.982

10.  Glucagon enhances growth of cultured human colorectal cancer cells in vitro.

Authors:  M P Moyer; J B Aust; P S Dixon; B A Levine; K R Sirinek
Journal:  Am J Surg       Date:  1985-12       Impact factor: 2.565

View more
  7 in total

1.  IGF-I and IGF-I receptor in mouse colon cancer cells.

Authors:  P Singh; Y S Guo; S Narayan; Y Chandrasekhar
Journal:  In Vitro Cell Dev Biol       Date:  1991-10

2.  Characterization of gastrin binding to colonic mucosal membranes of guinea pigs.

Authors:  S Narayan; L Chicione; P Singh
Journal:  Mol Cell Biochem       Date:  1992-06-26       Impact factor: 3.396

3.  Differences in plasma gastrin, CEA, and CA 19-9 concentration in patients with proximal and distal colorectal cancer.

Authors:  Grzegorz Bombski; Anita Gasiorowska; Daria Orszulak-Michalak; Beata Neneman; Justyna Kotynia; Janusz Strzelczyk; Adam Janiak; Ewa Malecka-Panas
Journal:  Int J Gastrointest Cancer       Date:  2002

4.  Identification of progastrin derived peptides in colorectal carcinoma extracts.

Authors:  J Nemeth; B Taylor; S Pauwels; A Varro; G J Dockray
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

5.  Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein.

Authors:  G S Baldwin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

Review 6.  Gastrin, gastrin receptors and colorectal carcinoma.

Authors:  G S Baldwin; A Shulkes
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

7.  Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin.

Authors:  M Blackmore; B H Hirst
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.